Trial Outcomes & Findings for A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC) (NCT NCT03693937)
NCT ID: NCT03693937
Last Updated: 2019-07-05
Results Overview
NMSC cure rate will be calculated as the percentage of lesions that attained complete cure following SRT-100 treatment completion.
Recruitment status
COMPLETED
Target enrollment
776 participants
Primary outcome timeframe
5 years
Results posted on
2019-07-05
Participant Flow
Participant milestones
| Measure |
Non-Melanoma Skin Cancers (NMSCs)
Non-Melanoma Skin Cancers (NMSCs) treated with SRT-100 therapy.
|
|---|---|
|
Overall Study
STARTED
|
776
|
|
Overall Study
COMPLETED
|
776
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)
Baseline characteristics by cohort
| Measure |
Non-Melanoma Skin Cancers (NMSCs)
n=516 Participants
Non-Melanoma Skin Cancers (NMSCs) treated with SRT-100 therapy.
|
|---|---|
|
Age, Continuous
|
78.94 years
STANDARD_DEVIATION 8.89 • n=99 Participants
|
|
Sex: Female, Male
Female
|
223 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
293 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Participant Race · Hispanic or Latino
|
0 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Participant Race · Not Hispanic or Latino
|
516 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Participant Race · Unknown or Not Reported
|
0 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
516 Participants
n=99 Participants
|
PRIMARY outcome
Timeframe: 5 yearsNMSC cure rate will be calculated as the percentage of lesions that attained complete cure following SRT-100 treatment completion.
Outcome measures
| Measure |
Non-Melanoma Skin Cancers (NMSCs)
n=760 lesions
Non-Melanoma Skin Cancers (NMSCs) treated with SRT-100 therapy.
|
|---|---|
|
Cure Rate
|
751 lesions
|
Adverse Events
Non-Melanoma Skin Cancers (NMSCs)
Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Non-Melanoma Skin Cancers (NMSCs)
n=776 participants at risk
Non-Melanoma Skin Cancers (NMSCs) treated with SRT-100 therapy.
|
|---|---|
|
Skin and subcutaneous tissue disorders
Radiation Dermatitis
|
0.77%
6/776 • 5 years
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place